Saluda Medical
Bloomington, US · Founded 2023 · Delaware corporation · 488 employees on LinkedIn · 5 known investors
Saluda Medical develops the Evoke spinal cord stimulation (SCS) system, which records the spinal cord's physiologic response to stimulation using Evoked Compound Action Potentials (ECAPs). The company builds neuromodulation therapies for chronic pain management, serving healthcare providers and patients.
Founders & leadership
GP
Greg PlamondonExecutive
KC
Kristin CapliceExecutive
BR
Barry ReganExecutive
JS
James SchuermannExecutive
GK
Geoffrey KinghornNamed on SEC filing
Board
JM
RF
Robert FaulknerBoard director
GB
Geoffrey BrookeBoard director
AC
Andrew CleelandBoard director
DG
Doug GodshallBoard director
RP
Robert PalmisanoBoard director
CL
Catherine LivingstoneBoard director
Investors · 5
Reported raises · per SEC filings
Form D private placements$180M disclosed across 2 of 3 rounds · 2023–2025
▶$30MraisedNov 2025 · 26 investors · Other Health CareRule 506(b)
▶$30MraisedNov 2025 · 26 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Greg PlamondonExecutive Officer
- Kristin CapliceExecutive Officer
- Juan-Pablo MasDirector
- Robert FaulknerDirector
- Doug GodshallDirector
- Geoffrey BrookeDirector
- Robert PalmisanoDirector
- Barry ReganExecutive Officer, Director
- Catherine LivingstoneDirector
- Chris BeareDirector
- Andrew CleelandDirector
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$150MraisedApr 2023 · 18 investors · Other Health CareRule 506(b)
▶$150MraisedApr 2023 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Doug GodshallDirector
- Robert FaulknerDirector
- Chris BeareDirector
- Robert PalmisanoDirector
- James SchuermannDirector, Executive Officer
- Greg PlamondonExecutive Officer
- Kristin CapliceExecutive Officer
- Juan-Pablo MasDirector
- Catherine LivingstoneDirector
- Andrew CleelandDirector
- Geoffrey BrookeDirector
- Geoffrey KinghornDirector
- Laureen DeBuonoDirector
- Offering amount
- $150M
- Amount sold
- $150M
- Sales commissions
- $6M
- Placement agents
- BofA Securities, Inc.
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Rf Surgical46 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Boston Scientific43 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Carepatron21 shared keywordsCarepatron provides practice management and clinical workflow software for healthcare clinicians. The platform handles scheduling, patient documentation, billing, and payments in a single application, targeting medical practitioners globally.
Genhealth20 shared keywordsGenHealth provides AI-based revenue cycle management and administrative automation for healthcare providers and DME teams, handling intake, eligibility, claims, prior authorization, denials, and appeals. Its browser agent extracts data from faxes and documents and routes it into EMR and billing systems, targeting independent physician groups and providers.
Companies competing with Saluda Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Saluda Medical do?
- Saluda Medical develops the Evoke spinal cord stimulation (SCS) system, which records the spinal cord's physiologic response to stimulation using Evoked Compound Action Potentials (ECAPs). The company builds neuromodulation therapies for chronic pain management, serving healthcare providers and patients.
- Who are Saluda Medical's investors?
- Saluda Medical's investors include Action Potential Venture Capital Ltd., Fidelity Investments, REDMILE, T. Rowe Price, Wellington Management.
- How much funding has Saluda Medical raised?
- Saluda Medical has disclosed $180M raised across 2 of its 3 known rounds.
- Where is Saluda Medical headquartered?
- Saluda Medical is headquartered in Bloomington, US.